The integration of these complementary therapies with GLP-1 agonists, whether injectable or oral, represents the future of comprehensive metabolic health management
To be clear, microdosing tirzepatide is considered off-label
Association Between Semaglutide or Tirzepatide research protocol and Residual Gastric [PMID: 41393547] Laboratory literature summary: Association Between Semaglutide or Tirzepatide research protocol and Residual Gastric Content: A Potential Danger During Upper Endoscopy
The six domains evaluated were within-study bias (risk of bias), across-study bias (small-study effect/publication bias), indirectness, imprecision, heterogeneity and incoherence (inconsistency)
In the post hoc analysis, the researchers used data of over 3,500 participants from the Semaglutide Treatment Effect in People with obesity (STEP) 1, 2, 3 and 5 trials
These approved forms come with pre-measured doses, making them easier to use and lowering dosing errors